Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ ASCRS mourns death of I. Howard Fine, MD ➤ New non-diffractive monofocal and toric IOLs ➤ 36-month results from clinical trials for new glaucoma device ➤ FDA grants IND to stem cell therapy intended to treat photoreceptor diseases ➤ Company launches ophthalmology-specific contract research organization ➤ ASCRS news and events
➤ Study: ocular manifestations of Mpox ➤ ‘World’s first’ spiral IOL designed with artificial intelligence ➤ First-in-human implantation of wireless IOP sensor ➤ Final patient visit for Phase 2 wet AMD treatment trial ➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy ➤ ASCRS news and events
➤ NDA submitted for presbyopia treatment ➤ FDA approves AMD treatment ➤ Primary endpoint achieved in Phase 3 trial of reproxalap for dry eye ➤ Clinical trial results that supported new excimer laser approval published ➤ Company updates on several clinical trials ➤ First patient dosed in Phase 2 trial for intravitreal steroid implant for DME treatment ➤ ASCRS news and events
➤ FDA 510(k) clearance granted to cataract surgery system ➤ Laser for POAG receives CE Mark ➤ Collaboration to develop dry eye treatment ➤ First patients enrolled in Phase 3 wet AMD trial ➤ New open-access textbook on lens power calculations ➤ ASCRS news and events
➤ Study: protein patterns in tears predict postop pain ➤ Tentative approval for generic glaucoma drug ➤ Nanodrug recovers optic nerve in glaucoma animal model ➤ Acquisition news ➤ ASCRS news and events
➤ FDA grants De Novo classification to ocular pressure adjusting pump ➤ Inaugural ‘State of Dry Eye’ survey ➤ Study: potentially higher risk for blinding ocular condition with semaglutide use ➤ Wet AMD treatment implant reintroduced ➤ Acquisition news ➤ ASCRS news and events
Recent changes to training have seen the addition of a requirement for trainees to perform five MIGS procedures as the primary surgeon. Requirements for tube shunts and trabeculectomy remain in place, but those in training can be the surgeon or assistant on five procedures. Several surgeons weighed in on these changes.
Glaucoma Editor Manjool Shah, MD, shared the topics covered in the section and his thoughts on opportunities for innovation. “It has been and continues to be a journey of progress, innovation, collective action, mutual support and growth, and fortunately, the glaucoma genie doesn’t seem to have run out of wishes left to grant,” he said.
Genetic testing for glaucoma is not quite ready for “primetime,” but it’s close. Two physicians provided their thoughts on the current state of glaucoma genetic testing, its potential utility for patients, and what’s on the wish list.
➤ Allogenic cell therapy receives FDA designations ➤ Robot delivers new treatment for wet AMD ➤ Health-related quality of life measure proposed for MIGS ➤ Company meets with FDA for pediatric myopia drug candidate ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.